Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,332 | -19,000 | -12,752 | -8,599 | -4,171 |
| Other Working Capital | -210 | 1,895 | -747 | -1,337 | -1,483 |
| Other Operating Activity | 1,368 | 4,858 | 3,717 | 2,558 | 1,296 |
| Operating Cash Flow | $-4,174 | $-12,247 | $-9,782 | $-7,378 | $-4,358 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,798 | 12,036 | 8,083 | 6,576 | 4,849 |
| Other Financing Activity | -1,293 | -382 | -258 | -208 | -153 |
| Financing Cash Flow | $15,505 | $11,654 | $7,825 | $6,368 | $4,696 |
| Beginning Cash Position | 18,533 | 19,126 | 19,126 | 19,126 | 19,126 |
| End Cash Position | 29,864 | 18,533 | 17,169 | 18,116 | 19,464 |
| Net Cash Flow | $11,331 | $-593 | $-1,957 | $-1,010 | $338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,174 | -12,247 | -9,782 | -7,378 | -4,358 |
| Free Cash Flow | -4,174 | -12,247 | -9,782 | -7,378 | -4,358 |